Home › Funds › Sofinnova Investments, Inc. › TENX
Sofinnova Investments, Inc. position in TENX
TENAX THERAPEUTICS INC · Health Care
Sofinnova Investments, Inc. reported holding 500,039 shares of TENX (TENAX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.3M, representing 0.39% of its reported portfolio and ranking #40 among its reported holdings. Sofinnova Investments, Inc. has disclosed TENX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s TENX position evolved
Sofinnova Investments, Inc. first disclosed a stake in TENX in Q1 2026 at 104,400 shares (US$1.7M). The position peaked in Q2 2026 at 500,039 shares, worth US$7.3M. Across 2 filings, Sofinnova Investments, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 500,039 shares valued at US$7.3M — an increase of 395,639 shares quarter over quarter.. Notable position changes include a 379% increase in Q2 2026 (shares fell 87% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 104.40K | $1.67M | New |
| Q2 2026 | 500.04K | $7.28M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TENX and 13F data
TENX (TENAX THERAPEUTICS INC) is a Health Care company. 103 other funds we track also report a position in TENX — the largest reported positions include Vivo Capital, LLC (US$36.4M), Stonepine Capital Management, LLC (US$9.6M), BVF INC/IL (US$4.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TENX
- Vivo Capital, LLC 2.50M sh · $36.38M · Q2 2026
- Stonepine Capital Management, LLC 660.00K sh · $9.60M · Q2 2026
- BVF INC/IL 339.55K sh · $4.94M · Q2 2026
- DIADEMA PARTNERS LP 307.00K sh · $4.47M · Q2 2026
- Avidity Partners Management LP 265.93K sh · $3.87M · Q2 2026
- Verdad Advisers, LP 123.17K sh · $1.79M · Q2 2026
- Tetragon Partners GP Ltd 75.10K sh · $1.09M · Q2 2026
- Creek Drive Management Group LLC 74.00K sh · $1.08M · Q2 2026
- Velan Capital Investment Management LP 68.70K sh · $999.59K · Q2 2026
- Artia Global Partners LP 42.08K sh · $612.26K · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held TENX?
Sofinnova Investments, Inc. has disclosed TENX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Sofinnova Investments, Inc.'s current position in TENX?
As of Q2 2026, Sofinnova Investments, Inc. holds 500.04K shares of TENX (TENAX THERAPEUTICS INC), valued at $7.28M, representing 0.39% of its reported portfolio and ranking #40.
Has Sofinnova Investments, Inc. been buying or selling TENX?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in TENX. The position peaked in Q2 2026 at 500.04K shares.
Which other funds hold TENX?
Other major institutional holders of TENX include Vivo Capital, LLC, Stonepine Capital Management, LLC, BVF INC/IL, among 103 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.